Dissecting the Gut Microbiota-MetaboliteCoronary Atherosclerosis Axis: Evidence from Two-Sample Mendelian Randomization [0.03%]
基于两样本孟德尔随机化证据解剖肠道微生态-代谢物-冠状动脉粥样硬化轴关系的研究
Qitian Sun,Zeyu Zhou,Yu Gao
Qitian Sun
Introduction: Coronary Atherosclerosis (CAS) is a complex disease influenced by host genes, the gut microbiota, and circulating metabolites. Causal relationships and mediating effects among these factors have not yet been...
Current Status and Review of Traditional Chinese Medicine Formula Granules in the Treatment of Bone and Joint Degenerative Diseases [0.03%]
中医药复方颗粒剂治疗骨关节退行性疾病的研究进展与现状分析
Zhong-Hao Wang,Xian-Quan Zhang,Zhuo-Xu Gu et al.
Zhong-Hao Wang et al.
Introduction: Degenerative bone and joint diseases pose significant challenges in aging societies, causing pain and functional limitations. Traditional Chinese Medicine (TCM) formula granules (TCMFG), which combine tradit...
Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress [0.03%]
牻牛儿醇通过抗炎和抗氧化作用对类风湿性关节炎的保护作用
Rubab Ejaz,Arham Shabbir,Zainab Khateeb et al.
Rubab Ejaz et al.
Introduction/objective: Rheumatoid arthritis is a chronic inflammatory disease of the joints. Geraniol, an acyclic monoterpene alcohol, is present in essential oils of various plants and is known to possess anti-inflammat...
Decoding Preeclampsia and Obesity: The Role of Immune Responses and Natural Product Interventions [0.03%]
子痫前期和肥胖的解码：免疫反应与天然产物干预的作用
Xi Long,Wene Liu,Jie Lin et al.
Xi Long et al.
Introduction: Preeclampsia (PE) is a pregnancy-specific disorder with high cerebrocardiovascular risk. Obesity increases PE risk, but current monotherapy remains insufficient. Shared mechanisms and natural product-based i...
Intervention Strategies using Agada (Ayurvedic Antitoxic Formulations) for Diseases caused by Endocrine Disruptors [0.03%]
利用阿嘎达（ ayurvedic抗毒配方）治疗内分泌干扰疾病的方法干预策略
Nilima Wadnerwar
Nilima Wadnerwar
Introduction: Chemicals consumed through food, water, air, and personal care products disrupt our endocrine system, contributing to a range of life-threatening diseases. Since this toxicity is cumulative, it is essential ...
Genetically Predicted 12,13-DiHOME Mediates the Association between TNF-Related Apoptosis-Inducing Ligand and Immune Thrombocytopenia [0.03%]
遗传预测的12,13-二氢愈创木脂素介导了肿瘤坏死因子相关凋亡诱导配体与免疫性血小板减少症之间的关联
Chendong Jiang,Yiwen Chen,Jun Liang et al.
Chendong Jiang et al.
Introduction: The role of Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) has been highlighted in autoimmune and metabolic disorders. However, there is still an inadequate explanation of its causal r...
Medication De-escalation in Type 2 Diabetes: A Review of Evidence-Based Strategies for Combination Therapy Reduction [0.03%]
2型糖尿病的药物减停策略：联合治疗方案减少的循证方法综述
Omar Oraibi
Omar Oraibi
This narrative review summarizes evidence on the topic of de-escalation of medications in patients with Type 2 Diabetes (T2D) who achieve glycemic control on combination therapy. The study reviews evidence from available clinical studies, e...
Modified Fuzi Lizhong Decoction Alleviates Colonic Lesions and Modulates Gut Microbiota in Diabetic Gastroparesis [0.03%]
附子理中汤改良方通过减轻糖尿病胃轻瘫(colonic lesions)患者的结肠病变及调节肠道菌群发挥作用研究
Xiaoxia An,Jinxiu Lan,Yongxiang Xie et al.
Xiaoxia An et al.
Introduction: Diabetic gastroparesis (DGP) is a debilitating complication of diabetes mellitus. This study investigated the therapeutic effects of Modified Fuzi Lizhong decoction (MFZLZD) on DGP. ...
Mechanistic Study of Yibi Decoction in Treating Rheumatoid Arthritis via Modulating the JAK2/STAT3 Signaling Pathway [0.03%]
益痹汤治疗类风湿关节炎调控JAK2/STAT3信号通路的机制研究
Chuanhong Huang,Shangtong Chen,Yueping Chen et al.
Chuanhong Huang et al.
Objective: To investigate the therapeutic effects of Yibi Decoction (YBD) in rheumatoid arthritis (RA) and to elucidate the underlying mechanisms, with a particular focus on the JAK/STAT signaling pathway. ...
Denosumab is Associated with Improved Liver Function and Reduced Fibrosis Scores in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease and Osteoporosis: A Retrospective Observational Study [0.03%]
denosumab与代谢功能异常相关肝脂肪变性肝病和骨质疏松患者的肝功能改善及纤维化评分降低有关：一项回顾性观察研究
Yuan Ruan,Dan Yu,Lei Shi
Yuan Ruan
Introduction: This study aimed to evaluate the effects of denosumab and alendronate on bone mineral density (BMD) and liver fibrosis markers in patients with both primary osteoporosis (OP) and metabolic dysfunction-associ...